$17.84
Price
$2.5B
Market Cap
—
P/E Ratio
-32.0
Forward P/E
$-0.32
EPS (TTM)
—
Dividend Yield
$172M
Cash
$753000
Total Debt
142M
Shares Out
$6.50
$20.15
52-Week Range
Institutional Ownership of TREVI THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for TREVI THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +232.4% | 5.1M | $47M | $7.42 | |
| 2025-Q2 | |||||
| SELL | -52.2% | 1.5M | $8M | $6.25 | |
| 2025-Q1 | |||||
| SELL | -26.6% | 3.2M | $20M | $4.29 | |
| 2022-Q3 | |||||
| BUY | NEW | 4.4M | $7M | $3.40 | |
Insider Trading for TREVI THERAPEUTICS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.